Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-01-11 @ 3:27 PM
Study NCT ID:
NCT00073502
Status:
COMPLETED
Last Update Posted:
2006-02-22
First Post:
2003-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
Sponsor:
OSI Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OSI-904-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None